|
Name |
Colletomellein A
|
Molecular Formula | C16H22O5 | |
IUPAC Name* |
(3S)-6,8-dihydroxy-3-(3-hydroxypentyl)-5,7-dimethyl-3,4-dihydroisochromen-1-one
|
|
SMILES |
CCC(CC[C@H]1CC2=C(C(=C(C(=C2C(=O)O1)O)C)O)C)O
|
|
InChI |
InChI=1S/C16H22O5/c1-4-10(17)5-6-11-7-12-8(2)14(18)9(3)15(19)13(12)16(20)21-11/h10-11,17-19H,4-7H2,1-3H3/t10?,11-/m0/s1
|
|
InChIKey |
ZYFJMOYLJGSVMD-DTIOYNMSSA-N
|
|
Synonyms |
Colletomellein A
|
|
CAS | NA | |
PubChem CID | 139587417 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 294.34 | ALogp: | 3.4 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 87.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 21 | QED Weighted: | 0.743 |
Caco-2 Permeability: | -4.854 | MDCK Permeability: | 0.00001140 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.778 |
Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.013 |
Blood-Brain-Barrier Penetration (BBB): | 0.23 | Plasma Protein Binding (PPB): | 95.72% |
Volume Distribution (VD): | 0.538 | Fu: | 3.43% |
CYP1A2-inhibitor: | 0.16 | CYP1A2-substrate: | 0.389 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.457 |
CYP2C9-inhibitor: | 0.035 | CYP2C9-substrate: | 0.753 |
CYP2D6-inhibitor: | 0.077 | CYP2D6-substrate: | 0.233 |
CYP3A4-inhibitor: | 0.085 | CYP3A4-substrate: | 0.196 |
Clearance (CL): | 15.708 | Half-life (T1/2): | 0.719 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.264 |
Drug-inuced Liver Injury (DILI): | 0.062 | AMES Toxicity: | 0.095 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.909 |
Skin Sensitization: | 0.821 | Carcinogencity: | 0.498 |
Eye Corrosion: | 0.008 | Eye Irritation: | 0.296 |
Respiratory Toxicity: | 0.68 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003669 | 0.778 | D07AHW | 0.243 | ||||
ENC003029 | 0.500 | D0WY9N | 0.241 | ||||
ENC002233 | 0.493 | D06XZW | 0.235 | ||||
ENC003148 | 0.417 | D04FBR | 0.222 | ||||
ENC003016 | 0.388 | D07MGA | 0.219 | ||||
ENC002497 | 0.380 | D0L5FY | 0.200 | ||||
ENC002496 | 0.380 | D03DJL | 0.200 | ||||
ENC005906 | 0.380 | D01WUA | 0.195 | ||||
ENC003354 | 0.371 | D0YH0N | 0.191 | ||||
ENC005913 | 0.371 | D0O1UZ | 0.190 |